RANDOMIZED TRIAL BETWEEN BEHENOYL CYTARABINE (BHAC) OR CYTARABINE IN COMBINATION CHEMOTHERAPY OF ADULT ACUTE MYELOID-LEUKEMIA (AML) (JALSG-AML89 PROTOCOL) AND ANALYSIS OF PROGNOSTIC FACTORS

KOBAYASHI T MIYAWAKI S TANIMOTO M KURIYAMA K MURAKAMI H YOSHIDA M KODERA Y MINATO K TSUBAKI K OHMOTO E OH H JINNAI I SAKAMAKI H HIRAOKA A KANAMARU A TAKAHASHI I FURUSAWA S NAOE T YAMADA O ASOU N NISHIKAWA K OKABE K OGURA M TANAKA M OHNO R

T. Kobayashi et al., RANDOMIZED TRIAL BETWEEN BEHENOYL CYTARABINE (BHAC) OR CYTARABINE IN COMBINATION CHEMOTHERAPY OF ADULT ACUTE MYELOID-LEUKEMIA (AML) (JALSG-AML89 PROTOCOL) AND ANALYSIS OF PROGNOSTIC FACTORS, Blood, 84(10), 1994, pp. 10000146-10000146

NO

Hematology

Blood → ACNP

00064971

84

10

1994

1

10000146 - 10000146

ISI

0006-4971(1994)84:10<10000146:RTBBC(>2.0.ZU;2-V